ATE149522T1 - Synthetische antigene zum nachweis von antikörpern gegen hepatitis c-virus - Google Patents

Synthetische antigene zum nachweis von antikörpern gegen hepatitis c-virus

Info

Publication number
ATE149522T1
ATE149522T1 AT94108611T AT94108611T ATE149522T1 AT E149522 T1 ATE149522 T1 AT E149522T1 AT 94108611 T AT94108611 T AT 94108611T AT 94108611 T AT94108611 T AT 94108611T AT E149522 T1 ATE149522 T1 AT E149522T1
Authority
AT
Austria
Prior art keywords
virus
hcv
antibodies against
against hepatitis
detecting antibodies
Prior art date
Application number
AT94108611T
Other languages
English (en)
Inventor
Robert J Deleys
Dirk Pollet
Geert Maertens
Heuverswyn Hugo Van
Original Assignee
Innogenetics Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26125651&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE149522(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Innogenetics Nv filed Critical Innogenetics Nv
Application granted granted Critical
Publication of ATE149522T1 publication Critical patent/ATE149522T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT94108611T 1990-12-14 1990-12-14 Synthetische antigene zum nachweis von antikörpern gegen hepatitis c-virus ATE149522T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SG1996005024A SG47062A1 (en) 1990-12-14 1990-12-14 Synthetic antigens for the detection of antibodies to hepatitis virus
EP90124241A EP0489968B1 (de) 1990-12-14 1990-12-14 Synthetische Antigene zum Nachweis von Antikörpern gegen Hepatitis C-Virus

Publications (1)

Publication Number Publication Date
ATE149522T1 true ATE149522T1 (de) 1997-03-15

Family

ID=26125651

Family Applications (3)

Application Number Title Priority Date Filing Date
AT94108611T ATE149522T1 (de) 1990-12-14 1990-12-14 Synthetische antigene zum nachweis von antikörpern gegen hepatitis c-virus
AT96201157T ATE185350T1 (de) 1990-12-14 1990-12-14 Synthetische antigene zum nachweis von antikörpern gegen hepatitis c virus
AT90124241T ATE144993T1 (de) 1990-12-14 1990-12-14 Synthetische antigene zum nachweis von antikörpern gegen hepatitis c-virus

Family Applications After (2)

Application Number Title Priority Date Filing Date
AT96201157T ATE185350T1 (de) 1990-12-14 1990-12-14 Synthetische antigene zum nachweis von antikörpern gegen hepatitis c virus
AT90124241T ATE144993T1 (de) 1990-12-14 1990-12-14 Synthetische antigene zum nachweis von antikörpern gegen hepatitis c-virus

Country Status (18)

Country Link
US (1) US5922532A (de)
EP (3) EP0489968B1 (de)
JP (1) JP2995216B2 (de)
KR (3) KR0181344B1 (de)
AT (3) ATE149522T1 (de)
AU (1) AU652013B2 (de)
BR (1) BR9106220A (de)
CY (2) CY2043A (de)
DE (2) DE69030124T2 (de)
DK (3) DK0754704T3 (de)
ES (3) ES2138784T3 (de)
GR (3) GR3022089T3 (de)
HK (1) HK57597A (de)
HU (1) HU218357B (de)
IL (1) IL100158A (de)
NZ (1) NZ240964A (de)
SG (1) SG47062A1 (de)
WO (1) WO1992010514A2 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5683864A (en) * 1987-11-18 1997-11-04 Chiron Corporation Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies
US5350671A (en) * 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
US6312889B1 (en) 1990-04-04 2001-11-06 Chiron Corporation Combinations of hepatitis c virus (HCV) antigens for use in immunoassays for anti-HCV antibodies
DE59109221D1 (de) * 1990-11-03 2001-11-15 Dade Behring Marburg Gmbh HCV-spezifische Peptide, Mittel dazu und ihre Verwendung
US5910404A (en) 1990-12-14 1999-06-08 Innogenetics N.V. Synthetic antigens for the detection of antibodies to hepatitis C virus
WO1992012992A2 (en) * 1991-01-14 1992-08-06 James N. Gamble Institute Of Medical Research Basic structural immunogenic polypeptides having epitopes for hcv, antibodies, polynucleotide sequences, vaccines and methods
WO1993000365A2 (en) 1991-06-24 1993-01-07 Chiron Corporation Hepatitis c virus (hcv) polypeptides
DE4209215A1 (de) * 1991-07-04 1993-01-07 Boehringer Mannheim Gmbh Hcv peptidantigene und verfahren zur bestimmung von hcv
US5811246A (en) * 1991-12-17 1998-09-22 The Research Foundation Of State University Of New York Process for immobilization onto the surfaces of ELISA plates of a compound carrier complex and for immunization
ZA928954B (en) * 1991-12-24 1993-05-19 Akzo Nv Peptides immunochemically reactive with antibodies directed against hepatitis non-A, non-B virus.
BR9305435A (pt) * 1992-03-06 1994-12-27 Innogenetics Nv Processo para determinação de peptídeos correspondendo a epítopos imunologicamente importantes e seu uso em um processo para determinação de anticorpos ou peptídeos biotinilados correspondendo a epítopos imunologicamente importantes, processo para preparação dos mesmos e composições contendo os mesmos
US6709828B1 (en) 1992-03-06 2004-03-23 N.V. Innogenetics S.A. Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them
US6667387B1 (en) 1996-09-30 2003-12-23 N.V. Innogenetics S.A. HCV core peptides
KR100317509B1 (ko) * 1992-07-16 2002-02-20 야스모토 토루 C형간염바이러스를분류하기위한항원성펩티드,이펩티드를포함하는키트및이펩티드를사용하는c형간염바이러스를분류하는방법
DE4240980A1 (de) * 1992-08-07 1994-02-10 Boehringer Mannheim Gmbh HCV Peptidantigene und Verfahren zur Bestimmung von HCV
CA2662090A1 (en) 1993-04-27 1994-11-10 N.V. Innogenetics S.A. New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
IT1270941B (it) * 1993-05-12 1997-05-26 Sorin Biomedica Spa Peptidi di hcv e loro usi.
US7070790B1 (en) * 1993-06-29 2006-07-04 The United States Of America As Represented By The Department Of Health And Human Services Nucleotide and deduced amino acid sequences of the envelope 1 and core genes of isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines
WO1996034013A1 (fr) * 1995-04-28 1996-10-31 Srl, Inc. Compose peptidique antigenique et methode de dosage immunologique
FR2775690B1 (fr) * 1998-03-09 2001-12-14 Bio Merieux Anticorps monoclonal et utilisations pour detecter des antigenes de la proteine core de vhc
WO1999058561A1 (fr) * 1998-05-14 1999-11-18 Pasteur Merieux Serums & Vaccins Mimotopes du virus de l'hepatite c
US7052830B1 (en) * 1998-06-09 2006-05-30 Branch Andrea D Hepatitis C virus peptides and uses thereof
ES2248357T3 (es) * 2000-07-07 2006-03-16 Medmira Inc. Composicion de antigeno mosaico de vhc.
AUPQ899400A0 (en) * 2000-07-26 2000-08-17 Csl Limited A method of stabilisation and compositions for use therein
JP4975600B2 (ja) * 2007-03-16 2012-07-11 シスメックス株式会社 Ｈｃｖ抗体測定用試薬キット及びｈｃｖ抗体測定方法
JP4975601B2 (ja) * 2007-03-16 2012-07-11 シスメックス株式会社 Ｈｃｖ抗体測定用試薬キット及びｈｃｖ抗体測定方法
EP1978365B1 (de) 2007-03-16 2010-08-25 Sysmex Corporation Reagenzkit und Verfahren zur Messung von HCV-Antikörpern
ES2303496B1 (es) * 2008-02-21 2009-07-07 Fundacion Para El Estudio De Las Hepatitis Virales Metodo analitico perfeccionado para la deteccion de hepatitis c oculta, aplicaciones del mismo y su correspondiente kit de diagnostico.
US20100104555A1 (en) * 2008-10-24 2010-04-29 The Scripps Research Institute HCV neutralizing epitopes
FR2987836A1 (fr) * 2012-03-09 2013-09-13 Biomerieux Sa Peptides d'interference et procede de detection de microorganismes

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US594854A (en) * 1897-12-07 Territory
US505611A (en) * 1893-09-26 Henry v
JP2702911B2 (ja) * 1985-09-11 1998-01-26 ユナイテツド・バイオメデイカル・インコ−ポレ−テツド 合成ペプチド、並びにそれを用いたエイズおよびプリ・エイズの検出方法
US4879212A (en) * 1986-04-02 1989-11-07 United Biomedical Inc. Peptide composition and method for the detection of antibodies to HTLV-III
US4749259A (en) * 1987-05-15 1988-06-07 Hughes Aircraft Company Liquid crystal image projection with multicolor prepolarizing system
US5350671A (en) * 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
ES2012739T5 (es) * 1987-11-18 2001-12-01 Chiron Corp Diagnosticos para nanbv.
WO1990011089A1 (en) * 1989-03-17 1990-10-04 Chiron Corporation Nanbv diagnostics and vaccines
AU638304B2 (en) * 1989-12-22 1993-06-24 Abbott Laboratories Hepatitis c assay
US5106726A (en) * 1990-02-16 1992-04-21 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV
KR940000755B1 (ko) * 1990-02-16 1994-01-29 유나이티드 바이오메디칼 인코오포레이티드 Hcv에 대한 항체 검출, hcv 감염의 진단 및 백신으로서의 그 예방에 특히 적합한 합성 펩티드
EP0445801A3 (en) * 1990-03-08 1992-07-01 Kuraray Co., Ltd. Peptide and its use
ZA912040B (en) * 1990-03-30 1991-12-24 Akzo Nv Peptides immunochemically reactive with antibodies directed against hepatitis non-a,non-b virus
UA41266C2 (uk) * 1990-04-04 2001-09-17 Чірон Корпорейшн Комбінація послідовностей епітопів вірусу гепатиту с (hcv), спосіб виявлення антитіл до вірусу гепатиту с (hcv), набір для виконання аналізу при виявленні антитіл до антигену гепатиту с (hcv)
AU660925B2 (en) * 1990-04-06 1995-07-13 Genelabs Technologies, Inc. Hepatitis C virus epitopes
AU635124B2 (en) * 1990-04-16 1993-03-11 United Biomedical Inc. Synthetic peptides specific for the detection of antibodies to HCV, diagnosis of HCV infection and prevention thereof as vaccines
WO1992001714A1 (en) * 1990-07-24 1992-02-06 Yamanouchi Pharmaceutical Co., Ltd. Non-a non-b hepatitis virus antigen
CA2047792C (en) * 1990-07-26 2002-07-02 Chang Y. Wang Synthetic peptides specific for the detection of antibodies to hcv, diagnosis of hcv infection and prevention thereof as vaccines
JP3114731B2 (ja) * 1990-08-14 2000-12-04 国立感染症研究所長 Ｃ型肝炎ウイルス抗体検出用ペプチド抗原及びその使用方法
AU673135B2 (en) * 1990-08-25 1996-10-31 New York Blood Center, Inc., The Non-A, non-B hepatitis virus antigen, diagnostic methods and vaccines
JP2949822B2 (ja) * 1990-10-03 1999-09-20 住友化学工業株式会社 熱可塑性樹脂組成物
DE59109221D1 (de) * 1990-11-03 2001-11-15 Dade Behring Marburg Gmbh HCV-spezifische Peptide, Mittel dazu und ihre Verwendung
CA2055149A1 (en) * 1990-11-08 1992-05-09 Hiroaki Okamoto Non-a, non-b hepatitis virus related antigen, antibody, detection systems, polynucleotides and polypeptides
KR920703640A (ko) * 1990-11-29 1992-12-18 테루카츄 아리마 비a비b형 간염 바이러스 항원 단백질
IE65424B1 (en) * 1991-03-01 1995-10-18 Akzo Nv Peptides immunochemically reactive with antibodies directed against hepatitis non-A non-B virus
FI923448A (fi) * 1991-08-02 1993-02-03 Akzo Nv Non-a, non-b-peptid
ZA927243B (en) * 1991-10-07 1994-01-26 Akzo Nv Non-A, Non-B peptides
BR9305435A (pt) * 1992-03-06 1994-12-27 Innogenetics Nv Processo para determinação de peptídeos correspondendo a epítopos imunologicamente importantes e seu uso em um processo para determinação de anticorpos ou peptídeos biotinilados correspondendo a epítopos imunologicamente importantes, processo para preparação dos mesmos e composições contendo os mesmos

Also Published As

Publication number Publication date
CY2053B1 (en) 1998-04-30
BR9106220A (pt) 1993-03-30
CY2043A (en) 1998-02-20
HU9202645D0 (en) 1993-01-28
GR3032150T3 (en) 2000-04-27
SG47062A1 (en) 1998-03-20
WO1992010514A2 (en) 1992-06-25
ATE185350T1 (de) 1999-10-15
EP0489968B1 (de) 1996-11-06
EP0754704A2 (de) 1997-01-22
EP0489968A1 (de) 1992-06-17
WO1992010514A3 (en) 1992-08-20
EP0644202B1 (de) 1997-03-05
JPH05503722A (ja) 1993-06-17
HK57597A (en) 1997-05-09
ES2095852T3 (es) 1997-03-01
DE69030124T2 (de) 1997-09-18
AU9068991A (en) 1992-07-08
EP0644202A1 (de) 1995-03-22
DK0489968T3 (da) 1997-03-24
ES2138784T3 (es) 2000-01-16
US5922532A (en) 1999-07-13
AU652013B2 (en) 1994-08-11
KR920703632A (ko) 1992-12-18
EP0754704B1 (de) 1999-10-06
KR0181344B1 (ko) 1999-04-01
DE69030124D1 (de) 1997-04-10
KR0181343B1 (ko) 1999-04-01
DK0754704T3 (da) 2000-04-03
ATE144993T1 (de) 1996-11-15
HUT65930A (en) 1994-07-28
IL100158A (en) 1998-02-22
ES2101388T3 (es) 1997-07-01
JP2995216B2 (ja) 1999-12-27
GR3023664T3 (en) 1997-09-30
NZ240964A (en) 1992-10-28
DK0644202T3 (da) 1997-09-15
GR3022089T3 (en) 1997-03-31
KR0181345B1 (ko) 1999-04-01
DE69029092T2 (de) 1997-04-17
EP0754704A3 (de) 1997-05-28
HU218357B (hu) 2000-08-28
DE69029092D1 (de) 1996-12-12

Similar Documents

Publication Publication Date Title
ATE185350T1 (de) Synthetische antigene zum nachweis von antikörpern gegen hepatitis c virus
FI20021626A (fi) Immuunimäärityksen reagenssi ja menetelmä hepatiitti C-viruksen (HCV) vasta-aineiden havaitsemiseksi
RU94024561A (ru) Иммунореактивные композиции, способ получения композиции, способы получения и обнаружения антител, набор днк, клетка-хозяин, способ получения белка
DE69126577D1 (de) Antigenes Peptid zum Nachweis von Anti-Hepatitis-C-Virus-Antikörpern und dessen Verwendung
SG145521A1 (en) Synthetic antigens for the detection of antibodies to hepatitis c virus
ATE120800T1 (de) Antigen-protein der sporozoit- und hepatischen phase von p. falciparum.
ATE360709T1 (de) Synthetische antigene zum nachweis von antikörpern mit immunreaktivität gegen hiv-virus
ATE117696T1 (de) Mit antikörper gegen hepatitis-virus non-a, non-b immunochemisch reagierende peptide.
FI102381B1 (fi) Epstein-Barrin viruksen tuma-antigeeniin (EBNA) liittyviä synteettisiä polypeptidejä ja menetelmä anti-EBNA-vasta-aineiden tunnistamiseksi kudosnäytteessä
DE69328488D1 (de) Peptide, analoge und ihre mischungen zur detektion und erzeugung von antikörpern gegen die e1 und e2 proteine des rubella virus
TW369600B (en) Antigenic peptides for grouping hepatitis C virus, kit comprising the same and methods for its grouping the same
DE69033316T2 (de) Synthetische Antigene zum Nachweis von Antikörpern gegen Hepatitis C Virus

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
RZN Patent revoked